NasdaqCM - Nasdaq Real Time Price USD

Outlook Therapeutics, Inc. (OTLK)

1.8250
-0.0750
(-3.95%)
As of 1:41:40 PM EDT. Market Open.

Insider Roster

Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.

Individual or EntityMost Recent TransactionDateShares Owned as of Transaction Date
EVANSON JEFF Officer Purchase Mar 7, 2024 808,459
HADDADIN YEZAN MUNTHER Director Purchase Mar 28, 2024 5,048
KENYON LAWRENCE A. Chief Financial Officer Purchase Sep 26, 2024 5,946
SUKHTIAN GHIATH M Director and Beneficial Owner of more than 10% of a Class of Security Stock Award(Grant) May 27, 2025 --
SYNTONE VENTURES, L.L.C. Beneficial Owner of more than 10% of a Class of Security Purchase Apr 15, 2024 1,705,440

Related Tickers